SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-17-003949
Filing Date
2017-03-07
Accepted
2017-03-07 16:34:43
Documents
1
Period of Report
2017-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 ANGOTTI rdgdoc.html 3  
1 FORM 3 ANGOTTI rdgdoc.xml 3 1414
  Complete submission text file 0001437749-17-003949.txt   2777
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Angotti Vincent J. (Reporting) CIK: 0001700225 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35068 | Film No.: 17672413